Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model

Malaria continues being a high-impact disease regarding public health worldwide; the WHO report for malaria in 2018 estimated that ~219 million cases occurred in 2017, mostly caused by the parasite Plasmodium falciparum. The disease cost the lives of more than 400,000 people, mainly in Africa. In sp...

Full description

Saved in:
Bibliographic Details
Main Authors: Jennifer Lambraño, Hernando Curtidor, Catalina Avendaño, Diana Díaz-Arévalo, Leonardo Roa, Magnolia Vanegas, Manuel E. Patarroyo, Manuel A. Patarroyo
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2019/3832513
Tags: Add Tag
No Tags, Be the first to tag this record!